Seven Early Warning Symptoms for Catching Cancer Early

We all know just how important it can be to catch lymphomas and all cancers in their early stages, but it's not very easy; many tumors give no indication whatsoever of their early development.

However, the American Cancer Society believes that we can learn to look for and recognize certain symptoms that may indicate that a tumor is building in our bodies. To that end they have established a list of 7 early warning symptoms and packaged them into an acronym, CAUTION:

  • Change in bowel/bladder habits
  • Asore that won't heal
  • Unusual bleeding or discharges
  • Thickening, lump in breast or another part of the body
  • Indigestion or problems swalloing
  • Obvious change in moles, warts
  • Nagging cough or hoarseness

Naturally, this doesn't mean that if you have one of these symptoms you have cancer. Rather, the list illustrates how a small but growing tumor starts to encroach upon the organs and functions around it in subtle ways, sometimes too subtle for us to catch. It doesn't have to be that way, it just requires a little more diligence on our parts to pay closer attention to what our bodies are trying to tell us.

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap